Analysis on endocrine and metabolic features of different phenotypes of polycystic ovary syndrome patients

To discuss the manifestations of endocrine and metabolism for polycystic ovary syndrome patients with different phenotype. this study selected 226 cases of rotterdam standard diagnosed polycystic ovary syndrome patients in people's hospital of zhengzhou from october 2013 to february 2015. the control group was the 100 cases of non hyperandrogen menstrual women as the control group. polycystic ovary syndrome included 4 phenotype: /or anovulatio (o) combined with hyperandrogenism (h) and polycystic ovary morphology (p),phenotype of o and p,phenotype of h and p,and phenotype of o and p. all patients were detected for the clinical endocrine and metabolism related parameters. the phenotype of o and p occupied 55.8%,it had significant difference on the comparison between control group and the luteinizing hormone (lh) and luteinizing hormone/follicle stimulating hormone (lh/fsh) of phenotype of o,h and p,phenotype of o and h and phenotype of o and p; the testosterone (t) of phenotype of o,h and p and phenotype of o and h was apparently higher than phenotype of o and p and control group; the total cholesterol (tc) and triglyceride (tg) in phenotype of o,h and p was greatly higher than phenotype of o and p and control group. the phenotype of o and p was the most common phenotype in pcos patients. it was same for the clinical endocrine and metabolism of two classic characteristics in pcos. compared to other pcos phenotype,the metabolism in phenotype of o and p was lower. the phenotype classification of pcos patients could better guide clinical individualized treatment in patients with pcos.